Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2019 08:00 ET | Source: VBI Vaccines, Inc.

VBI Vaccines Provides Update on GBM Program and Announces Upcoming Conference Call

10mcg dose selected to advance into Part B of Phase 1/2a study of VBI-1901 in recurrent GBMExpanded data from Part A of the Phase 1/2a study of VBI-1901 selected for poster presentation at...